SEC Comment Letter 0000000000-24-004652 to Revolution Medicines, Inc. (RVMD, RVMDW) (CIK 0001628171) (RVMD)
Revolution Medicines, Inc. (RVMD, RVMDW) (CIK 0001628171)
Date: April 26, 2024 · CIK: 0001628171 · Accession: 0000000000-24-004652
AI Filing Summary & Sentiment
File numbers found in text: 001-39219
Letter
United States securities and exchange commission logo April 26, 2024 Jack Anders Chief Financial Officer Revolution Medicines, Inc. 700 Saginaw Drive Redwood City, CA 94063 Re:Revolution Medicines, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-39219 Dear Jack Anders: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
April 26, 2024
Jack Anders
Chief Financial Officer
Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City, CA 94063
Re:Revolution Medicines, Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-39219
Dear Jack Anders:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences